2012Unpublished venueRequires access

Radiofrequency ablation of bone tumours (osteoid-osteoma and osseous metastases)

Marcus Warmuth, A. Nachtnebel

Open publisher page 0 citations

Abstract

Radiofrequency ablation (RFA) is a relatively new, minimally-invasive ablation method that destroys tumours by local application of heat. In terms of RFA for the treatment of osteoid-osteomas and osseous metastases, we included four and two prospective case-series respectively, with a total of 175 and 79 patients resp. According to GRADE, the quality of evidence is very low due to the uncontrolled study design of the included case-series. Overall, the available evidence is insufficient to assess the efficacy and safety of RFA compared to the respective standard therapy for the treatment of bone tumours.

About this research paper

What this paper is about

Radiofrequency ablation (RFA) is a relatively new, minimally-invasive ablation method that destroys tumours by local application of heat. In terms of RFA for the treatment of osteoid-osteomas and osseous metastases, we included four and two prospective case-series respectively, with a total of 175 and 79 patients resp. According to GRADE, the quality of evidence is very low due to the uncontrolled study design of the included case-series. Overall, the available evidence is insufficient to assess the efficacy and safety of RFA compared to the respective standard therapy for the treatment of bone tumours.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Radiofrequency ablation (RFA) is a relatively new, minimally-invasive ablation method that destroys tumours by local application of heat. In terms of RFA for the treatment of osteoid-osteomas and osseous metastases, we included four and two prospective case-series respectively, with a total of 175 and 79 patients resp. According to GRADE, the quality of evidence is very low due to the uncontrolled study design of the included case-series. Overall, the available evidence is insufficient to assess the efficacy and safety of RFA compared to the respective standard therapy for the treatment of bone tumours.

Key concepts: Osteoid osteoma, Medicine, Osteoid, Radiofrequency ablation, Ablation, Radiology, Osteosarcoma, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Radiofrequency ablation of bone tumours (osteoid-osteoma and osseous metastases) — Research Paper | ScholarLens